Transcriptional and Non-Transcriptional Functions of PPARβ/δ in Non-Small Cell Lung Cancer.

Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is a nuclear receptor involved in regulation of lipid and glucose metabolism, wound healing and inflammation. PPARβ/δ has been associated also with cancer. Here we investigated the expression of PPARβ/δ and components of the prostaglandin bios...

Full description

Bibliographic Details
Main Authors: Davide Genini, Ramon Garcia-Escudero, Giuseppina M Carbone, Carlo V Catapano
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23049921/pdf/?tool=EBI
_version_ 1818700944936796160
author Davide Genini
Ramon Garcia-Escudero
Giuseppina M Carbone
Carlo V Catapano
author_facet Davide Genini
Ramon Garcia-Escudero
Giuseppina M Carbone
Carlo V Catapano
author_sort Davide Genini
collection DOAJ
description Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is a nuclear receptor involved in regulation of lipid and glucose metabolism, wound healing and inflammation. PPARβ/δ has been associated also with cancer. Here we investigated the expression of PPARβ/δ and components of the prostaglandin biosynthetic pathway in non-small cell lung cancer (NSCLC). We found increased expression of PPARβ/δ, Cox-2, cPLA(2), PGES and VEGF in human NSCLC compared to normal lung. In NSCLC cell lines PPARβ/δ activation increased proliferation and survival, while PPARβ/δ knock-down reduced viability and increased apoptosis. PPARβ/δ agonists induced Cox-2 and VEGF transcription, suggesting the existence of feed-forward loops promoting cell survival, inflammation and angiogenesis. These effects were seen only in high PPARβ/δ expressing cells, while low expressing cells were less or not affected. The effects were also abolished by PPARβ/δ knock-down or incubation with a PPARβ/δ antagonist. Induction of VEGF was due to both binding of PPARβ/δ to the VEGF promoter and PI3K activation through a non-genomic mechanism. We found that PPARβ/δ interacted with the PI3K regulatory subunit p85α leading to PI3K activation and Akt phosphorylation. Collectively, these data indicate that PPARβ/δ might be a central element in lung carcinogenesis controlling multiple pathways and representing a potential target for NSCLC treatment.
first_indexed 2024-12-17T15:13:00Z
format Article
id doaj.art-9ac73be4b28044339e5ff6ec2ac3344f
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-17T15:13:00Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-9ac73be4b28044339e5ff6ec2ac3344f2022-12-21T21:43:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0179e4600910.1371/journal.pone.0046009Transcriptional and Non-Transcriptional Functions of PPARβ/δ in Non-Small Cell Lung Cancer.Davide GeniniRamon Garcia-EscuderoGiuseppina M CarboneCarlo V CatapanoPeroxisome proliferator-activated receptor β/δ (PPARβ/δ) is a nuclear receptor involved in regulation of lipid and glucose metabolism, wound healing and inflammation. PPARβ/δ has been associated also with cancer. Here we investigated the expression of PPARβ/δ and components of the prostaglandin biosynthetic pathway in non-small cell lung cancer (NSCLC). We found increased expression of PPARβ/δ, Cox-2, cPLA(2), PGES and VEGF in human NSCLC compared to normal lung. In NSCLC cell lines PPARβ/δ activation increased proliferation and survival, while PPARβ/δ knock-down reduced viability and increased apoptosis. PPARβ/δ agonists induced Cox-2 and VEGF transcription, suggesting the existence of feed-forward loops promoting cell survival, inflammation and angiogenesis. These effects were seen only in high PPARβ/δ expressing cells, while low expressing cells were less or not affected. The effects were also abolished by PPARβ/δ knock-down or incubation with a PPARβ/δ antagonist. Induction of VEGF was due to both binding of PPARβ/δ to the VEGF promoter and PI3K activation through a non-genomic mechanism. We found that PPARβ/δ interacted with the PI3K regulatory subunit p85α leading to PI3K activation and Akt phosphorylation. Collectively, these data indicate that PPARβ/δ might be a central element in lung carcinogenesis controlling multiple pathways and representing a potential target for NSCLC treatment.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23049921/pdf/?tool=EBI
spellingShingle Davide Genini
Ramon Garcia-Escudero
Giuseppina M Carbone
Carlo V Catapano
Transcriptional and Non-Transcriptional Functions of PPARβ/δ in Non-Small Cell Lung Cancer.
PLoS ONE
title Transcriptional and Non-Transcriptional Functions of PPARβ/δ in Non-Small Cell Lung Cancer.
title_full Transcriptional and Non-Transcriptional Functions of PPARβ/δ in Non-Small Cell Lung Cancer.
title_fullStr Transcriptional and Non-Transcriptional Functions of PPARβ/δ in Non-Small Cell Lung Cancer.
title_full_unstemmed Transcriptional and Non-Transcriptional Functions of PPARβ/δ in Non-Small Cell Lung Cancer.
title_short Transcriptional and Non-Transcriptional Functions of PPARβ/δ in Non-Small Cell Lung Cancer.
title_sort transcriptional and non transcriptional functions of pparβ δ in non small cell lung cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23049921/pdf/?tool=EBI
work_keys_str_mv AT davidegenini transcriptionalandnontranscriptionalfunctionsofpparbdinnonsmallcelllungcancer
AT ramongarciaescudero transcriptionalandnontranscriptionalfunctionsofpparbdinnonsmallcelllungcancer
AT giuseppinamcarbone transcriptionalandnontranscriptionalfunctionsofpparbdinnonsmallcelllungcancer
AT carlovcatapano transcriptionalandnontranscriptionalfunctionsofpparbdinnonsmallcelllungcancer